New drug shows promise in reversing memory loss for early Alzheimer’s patients

Posted by Michael Jannicelli | Feb 5, 2025 | Uncategorized | 0 |

A paradigm-shifting study shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer’s disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, offering hope for improving cognitive functioning, delaying Alzheimer’s progression, and potentially preventing some of the brain damages associated with the disease.

About The Author

Michael Jannicelli

Michael Jannicelli - "A PROVEN BUSINESS FIRESTARTER & BRANDING GENIUS" a true natural born Trendsetter. • Created over 100 products under 3 brands, sold in 30+ countries worldwide and influencing youth across the globe. • Featured in Forbes magazine +over 100 print publications, television talk shows, major motion pictures and national radio stations. • Co-founder and VP of Bliss beverage USA and President/co-founder of Socko International - fastest growing privately held beverage company in US (Forbes) with Hogan Energy & Raw Energy WWE. • Co-founder of Throwdown Industries (2003) - leading brand in multibillion dollar Impact/Action Sports Market (products designed for superior MN • Diagnosed with auto-immune diseases aged 13; using his experience to help others and promote a positive message while developing edgy products to benefit people with chronic illness.